OSPT LTD
ActiveKey figures
Like most small UK companies, OSPT LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2024/25Sector comparison
SIC 72110Where the company stands among the 3,991 active companies whose first SIC code is 72110 (Research and experimental development on biotechnology).
- BRACCO HORIZONS LIMITED£526.1m
- TAURX THERAPEUTICS MANAGEMENT LTD.£470.3m
- LABCORP EARLY DEVELOPMENT LABORATORIES LIMITED£317m
- JAZZ PHARMACEUTICALS RESEARCH UK LIMITED£289.2m
- GENOME RESEARCH LIMITED£273.7m
- MODERNA BIOTECH UK LIMITED£236.5m
- CURIA (SCOTLAND) LIMITED£183m
- ASTEX THERAPEUTICS LIMITED£163.6m
- HORIZON DISCOVERY GROUP LIMITED£159.6m
- AMGEN LIMITED£134.4m
Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant, so those groups are smaller than 3,991. The line on each bar marks the median.
Summary: OSPT LTD
What kind of company is it?
OSPT LTD is a private limited company registered with Companies House under company number 12089475. It was incorporated on 6 Jul 2019. Its status is active. The registered office is in Oxford (OX5). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).
How is the company doing financially?
The latest accounts in the database are for 2024/25 (period ending 31 Jul 2025); the company files small company accounts (filleted). Net assets were £224,031, down 0.5% on the previous year. Cash at bank and in hand was £160,985. The company had an average of 6 employees. Figures are available for 6 financial years (2019/20–2024/25).
How does it compare with similar companies?
Compared with 3,991 active companies whose first SIC code is 72110: By net assets it ranks higher than 71% of them (median £20,780). By total assets it ranks higher than 60% of them (median £125,608). By cash it ranks higher than 55% of them (median £101,821). By number of employees it ranks higher than 83% of them (median 1). It is older than 61% of them (median age 5.4 years).
Has it received government grants?
It is recorded as the recipient of 5 central government grants worth £799.8k, mainly from Department for Science, Innovation and Technology.
What do public registers and reports show?
It appears on the Home Office register of licensed sponsors (Skilled Worker).
Who runs and controls the company?
The company has 3 current directors. One person with significant control is registered.
When are its next filings due?
The next accounts are due by 30 Apr 2027. The next confirmation statement is due by 19 Jul 2027.
Filed accounts2019/20–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | 31,254 | 164,302 | 82,491 | 146,882 | 160,985 |
| Total assets | 43,814 | 205,428 | 158,283 | 260,132 | 259,031 |
| Total liabilities | — | — | — | — | — |
| Net assets / total equity | -2,437 | 146,428 | 123,283 | 225,132 | 224,031 |
| Average number of employees | 2 | 2 | 3 | 5 | 6 |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Government grants
5 grantsOSPT LTD is recorded as the recipient of 5 central government grants since 2022, together worth £799.8k.
- Department for Science, Innovation and Technology
- 4 grants · £633.6k
- Department for Business, Energy and Industrial Strategy
- 1 grant · £166.2k
- Preventing Cardiovascular Implant InfectionsDepartment for Science, Innovation and Technology · £99,895 · UKRI - Innovate UK - Scheme
- Bacteriophages against surgical site infectionsDepartment for Science, Innovation and Technology · £50,277 · UKRI - Innovate UK - Scheme
- Bacteriophages against surgical site infectionsDepartment for Science, Innovation and Technology · £342,955 · UKRI - Innovate UK - Scheme
- Novel antibacterial surgical suturesDepartment for Business, Energy and Industrial Strategy · £166,221 · UKRI - Innovate UK - Scheme 22/23
- Novel antibacterial surgical suturesDepartment for Science, Innovation and Technology · £140,475 · UKRI - Innovate UK - Scheme
From the Government Grants Register published by the Cabinet Office (financial years 2016/17 onwards, Open Government Licence v3.0). It covers grants from central government departments and their agencies where the register states the recipient's company number and the recipient name matches this company; grants from local authorities, lottery distributors and devolved governments are not included.
Registers and licences
- Licence type and rating
- Worker (A rating)
- Route
- Skilled Worker
On the Home Office register of licensed sponsors, which lists organisations licensed to sponsor workers from overseas.
Sources: Charity Commission for England and Wales, Care Quality Commission, Home Office and HM Revenue & Customs, under the Open Government Licence v3.0. Entries marked ‡ come from lists that do not state a company number and were linked by an exact match on the registered name.
History
23 events- Mr Ian Mark Bingham ceased to be a person with significant control
- Mr Ian Mark Bingham registered as a person with significant control
- Financial year 2024/25 endedAccounts: net assets £224k, 6 employees
- Financial year 2023/24 endedAccounts: net assets £225.1k, 5 employees
- Name changed to OSPT LTDPreviously OXFORD SILK PHAGE TECHNOLOGIES LIMITED
- Financial year 2022/23 endedAccounts: net assets £123.3k, 3 employees
- Mr Ian Mark Bingham ceased to be a person with significant control
- David JANESON appointedDirector
Earlier events (15)
- Financial year 2021/22 endedAccounts: net assets £146.4k, 2 employees
- David LASKOW-POOLEY resignedDirector
- Ian Mark BINGHAM resignedDirector
- Financial year 2020/21 endedAccounts: net assets −£2,437, 2 employees
- David LASKOW-POOLEY appointedDirector
- Ian Mark BINGHAM appointedDirector
- David LASKOW-POOLEY appointedDirector
- Mr Ian Mark Bingham registered as a person with significant control
- Mr James Gilbert ceased to be a person with significant control
- Financial year 2019/20 endedAccounts: net assets £45.8k, 2 employees
- Name changed to OXFORD SILK PHAGE TECHNOLOGIES LIMITEDPreviously VASCULAR SILK TECHNOLOGIES LTD
- Stephanie Laure LESAGE appointedDirector
- Ms Stephanie Laure Lesage registered as a person with significant control
- Mr James Gilbert registered as a person with significant control
- Company incorporatedPrivate limited company
Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current and former persons with significant control, and the end of each financial year with figures in the database.